Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly ...
Women with high-risk HER2-positive breast cancer lived significantly longer with adjuvant trastuzumab emtansine (T-DM1, ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
Claire took on the route with her aim to raise funds for breast cancer patients in the Ulster Hospital who are undergoing ...
Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...
Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.
Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...